Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

BACKGROUND: The aim of this study was to evaluate the proportion of patients with ankylosing spondylitis maintaining clinical remission after reduction of their subcutaneous etanercept dose to 50 mg every other week compared with that in patients receiving etanercept 50 mg weekly. METHODS: In the fi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cantini, Fabrizio, Niccoli, Laura, Cassarà, Emanuele, Kaloudi, Olga, Nannini, Carlotta
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3540908/
https://ncbi.nlm.nih.gov/pubmed/23319853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S31474
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky